✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹320 Cr.
P/E
60.91

Key Ratios

Market cap
Market cap
320 Cr
PE
PE
60.91
Prom Holding
Prom Holding
68.84 %
ROE (%)
ROE (%)
9.17
ROCE (%)
ROCE (%)
12.93
Div Yield (%)
Div Yield (%)
-
Sales
Sales
42.78 Cr
OPM (%)
OPM (%)
30.88 %
Debt to Equity
Debt to Equity
-

About

Zenotech Laboratories Ltd develops and manufactures generic biopharmaceuticals to address unme… Read more
Low
49
52W Range
High
95
  • Zenotech Laboratorie
  • Vivo Bio Tech
  • Jeevan Scientific
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

Customers

  • Sun Pharmaceutical Industries Ltd.

FAQs on Zenotech Laboratories Ltd. Business

Zenotech Laboratories Ltd specializes in developing and manufacturing generic biopharmaceuticals to meet global medical needs. They offer services for generating and characterizing recombinant proteins, covering gene cloning to protein production.

Zenotech Laboratorie major competitors are Vivo Bio Tech, Jeevan Scientific, Sun Pharma Adv. Res, Dishman Carbogen Amc, Syngene Internation., Hikal, Suven Life Sciences.
Market Cap of Zenotech Laboratorie is ₹312 Crs.
While the median market cap of its peers are ₹4,186 Crs.

Zenotech Laboratorie seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material